2024 2023

Puig, N, Agullo, C, Contreras, T, Perez, JJ, Aires, I, Calasanz, MJ, Garcia-Sanz, R, Castro, S, Martinez-Lopez, J, Rodriguez-Otero, P, Gonzalez-Calle, V, Gonzalez, MS, Oriol, A, Gutierrez, NC, Rios-Tamayo, R, Rosinol, L, Alvarez, MA, Bargay, J, Gonzalez-Rodriguez, AP, Alegre, A, Escalante, F, Inigo, MB, de la Rubia, J, Teruel, AI, de Arriba, F, Palomera, L, Hernandez, MT, Lopez-Jimenez, J, Reinoso, M, Garcia-Mateo, A, Ocio, EM, Blade, J, Lahuerta, JJ, Cedena, MT, Paiva, B, Miguel, JFS, Mateos, MV. Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome inpatients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial. HAEMATOLOGICA 109 4056-4066. 1 dic 2024. . . F.I.:8,200 [doi:10.3324/haematol.2024.285742]

Guerrero-Murillo, M, Rill-Hinarejos, A, Trincado, JL, Bataller, A, Ortiz-Maldonado, V, Benítez-Ribas, D, Español-Rego, M, González-Navarro, E, Martínez-Cibrián, N, Marchese, D, Martín-Martín, L, García-Sancho, AM, Rives, S, Heyn, H, Juan, ME, Urbano-Ispizúa, A, Delgado, J, Orfao, A, Mereu, E, Bueno, C, Menendez, P. Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias. CELL REP MED 5 -. 19 nov 2024. 1 nov 2024. . F.I.:11,700 [doi:10.1016/j.xcrm.2024.101803]

Di Staso, R, Casadei, B, Locke, FL, Jain, M, Voorhees, TJ, Kittai, AS, Bastos-Oreiro, M, Gutiérrez, A, Garcia-Sancho, AM, Terol, MJ, Mead, M, Maranzano, MJ, Iacoboni, G, Barba, P, Kwon, M, Bailen, R, Reguera-Ortega, JL, Mian, A, Hill, B, Bachy, E, Morschhauser, F, Houot, R, Thieblemont, C, Le Gouill, S, Masetti, R, Gori, D, Broccoli, A, Zinzani, PL, Argnani, L. Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma. BLOOD CANCER J 14 -. 7 nov 2024. . . F.I.:12,900 [doi:10.1038/s41408-024-01183-8]

Gil-Etayo, FJ, Niño-Ramírez, JE, Fonseca-Santos, M, Arroyo-Sánchez, D, Navarro-Bailón, A, Parra, AV, Hernaz, IJ, Sánchez, PT, Boix, F, Alcoceba, M, Marin, L, Pérez-López, E, Cabrero, M, Martín-López, AA, López, M, Baile, M, Avendaño, A, Cabero, A, García-Bacelar, A, Vázquez, L, Sánchez-Guijo, F, García-Sanz, R, López-Corral, L, Velarde, AT. Quantifying HLA Mismatches at Epitope Level in Haplo-HSCT: Impact in the Outcome in Strategies Using PTCy. HLA 104 -. 1 nov 2024. . . F.I.:5,900 [doi:10.1111/tan.15738]
Iacoboni, G, Navarro, V, Sesques, P, Rejeski, K, Bastos-Oreiro, M, Serpenti, F, Lopez, AAM, Iraola-Truchuelo, J, Delgado, J, Perez, A, Guerreiro, M, Caballero, AC, Martinez-Cibrian, N, Henriquez, HL, Pina, JMS, Sancho, JM, Ghesquieres, H, Mussetti, A, Corral, LL, Hernani, R, Reguera, JL, Sureda, A, Bosch, F, Garcia-Sancho, AM, Kwon, M, Subklewe, M, Kuhnl, A, Bachy, E, Barba, P, Villacampa, G, Abrisqueta, P. Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment. J HEMATOL ONCOL 17 -. 29 oct 2024. . . F.I.:29,500 [doi:10.1186/s13045-024-01608-8]

Bailén, R, Iacoboni, G, Delgado, J, López-Corral, L, Hernani-Morales, R, Ortiz-Maldonado, V, Guerreiro, M, Caballero, AC, Guerra-Domínguez, ML, Sánchez-Pina, JM, Peña, M, Torrent, A, Pérez-Martínez, A, Bastos-Oreiro, M, Reguera-Ortega, JL, Martín, A, Hernandez-Boluda, JC, Martínez-Cibrián, N, Sanz, J, Briones, J, Henriquez, HL, Calbacho, M, Mussetti, A, Sancho, JM, Barba, P, Kwon, M. Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO. TRANSPL CELL THER 30 -. 1 oct 2024. 1 sep 2024. . F.I.:3,600 [doi:10.1016/j.jtct.2024.06.022]
Rivas-Delgado, A, López, C, Clot, G, Nadeu, F, Grau, M, Frigola, G, Bosch-Schips, J, Radke, J, Ishaque, N, Alcoceba, M, Tapia, G, Luizaga, L, Barcena, C, Kelleher, N, Villamor, N, Baumann, T, Muntañola, A, Sancho-Cia, JM, García-Sancho, AM, Gonzalez-Barca, E, Matutes, E, Brito, JA, Karube, K, Salaverria, I, Enjuanes, A, Wiemann, S, Heppner, FL, Siebert, R, Climent, F, Campo, E, Giné, E, López-Guillermo, A, Beà, S. Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL. HEMASPHERE 8 -. 1 oct 2024. . . F.I.:7,600 [doi:10.1002/hem3.70024]

Witzig, T, Sokol, L, Kim, WS, Vicente, FD, García-Sancho, AM, Advani, R, Vidal, JMR, Navarrete, RD, Marín-Niebla, A, Izquierdo, AR, Terol, MJ, Domingo-Domenech, E, Saunders, A, Bendris, N, Mackey, J, Leoni, M, Foss, F. Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma. BLOOD ADV 8 4581-4592. 10 sep 2024. 1 ago 2024. . F.I.:7,400 [doi:10.1182/bloodadvances.2024012806]

Rey-Búa, B, Grande, C, Blanco, JJS, Abrisqueta, P, Gutiérrez, A, Páyer, AR, Giné, E, Etxetxipia, IZ, Terol, MJ, Vicente, FD, Andreu, R, Ramirez, MJ, de la Fuente, A, Viguria, MC, Peñarrubia, MJ, Jiménez-Ubieto, A, Montes-Moreno, S, López-Guillermo, A, Caballero, MD, García-Sancho, AM. Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group. CLIN CANCER RES 30 3704-3714. 3 sep 2024. . . F.I.:10,000 [doi:10.1158/1078-0432.CCR-24-0183]
Chatzikonstantinou, T, Scarfò, L, Minga, E, Karakatsoulis, G, Chamou, D, Kotaskova, J, Iacoboni, G, Demosthenous, C, Albi, E, Alcoceba, M, Al-Shemari, S, Aurran-Schleinitz, T, Bacchiarri, F, Chatzileontiadou, S, Collado, R, Davis, Z, Santos, MDD, Dimou, M, Dmitrieva, E, Donaldson, D, Dos Santos, G, Dreta, B, Efstathopoulou, M, El-Ashwah, S, Enrico, A, Frygier, A, Galimberti, S, Galitzia, A, Gimeno, E, Guarente, V, Guieze, R, Harrop, S, Hatzimichael, E, Herishanu, Y, Hernández-Rivas, JA, Jaksic, O, Kalicinska, E, Laribi, K, Karakus, V, Kater, AP, Kho, B, Kislova, M, Konstantinou, E, Koren-Michowitz, M, Kotsianidis, I, Kubova, Z, Labrador, J, Lad, D, Laurenti, L, Longval, T, Lopez-Garcia, A, Marquet, J, Maslejova, S, Mayor-Bastida, C, Mihaljevic, B, Milosevic, I, Miras, F, Moia, R, Morawska, M, Nath, UK, Navarro-Bailón, A, Olivieri, J, Panovska-Stavridis, I, Papaioannou, M, Pierie, C, Puiggros, A, Reda, G, Rigolin, GM, Ruchlemer, R, Schipani, M, Schiwitza, A, Shen, YD, Shokralla, T, Simkovic, M, Smirnova, S, Soliman, DSA, Stilgenbauer, S, Tadmor, T, Tomic, K, Tse, E, Vassilakopoulos, T, Visentin, A, Vitale, C, Vrachiolias, G, Vukovic, V, Walewska, R, Xu, ZS, Yagci, M, Yañez, L, Yassin, M, Zuchnicka, J, Oscier, D, Gozzetti, A, Panagiotidis, P, Bosch, F, Sportoletti, P, Espinet, B, Pangalis, GA, Popov, VM, Mulligan, S, Angelopoulou, M, Demirkan, F, Papajík, T, Biderman, B, Murru, R, Coscia, M, Tam, C, Cuneo, A, Gaidano, G, Claus, R, Stavroyianni, N, Trentin, L, Antic, D, Smolej, L, Kalashnikova, OB, Catherwood, M, Spacek, M, Pospisilova, S, Doubek, M, Nikitin, E, Chatzidimitriou, A, Ghia, P, Stamatopoulos, K. Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. HEMASPHERE 8 -. 1 sep 2024. . . F.I.:7,600 [doi:10.1002/hem3.70004]